GRI Bio, Inc. (GRI)
2.06
-0.14
(-6.36%)
USD |
NASDAQ |
May 22, 16:00
2.06
0.00 (0.00%)
After-Hours: 20:00
GRI Bio EPS Diluted (Quarterly) : -1.61 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Agenus, Inc. | 1.023 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
| Anika Therapeutics, Inc. | -0.3737 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.998M |
| Total Expenses (Quarterly) | 1.998M |
| Enterprise Value | -7.342M |
| Earnings Yield | -3.86K% |
| Normalized Earnings Yield | -3861.71 |